Globus Medical, Inc. (GMED) News

Globus Medical, Inc. (GMED): $64.53

-1.19 (-1.81%)

POWR Rating

Component Grades













Filter GMED News Items

GMED News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GMED News Highlights

  • For GMED, its 30 day story count is now at 15.
  • Over the past 23 days, the trend for GMED's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • The most mentioned tickers in articles about GMED are BEAT, VIEW and DAVE.

Latest GMED News From Around the Web

Below are the latest news stories about Globus Medical Inc that investors may wish to consider to help them evaluate GMED as an investment opportunity.

Globus Medical, Inc. (GMED) CEO David Demski on Q4 2021 Results - Earnings Call Transcript

Globus Medical, Inc. (GMED) Q4 2021 Earnings Conference Call February 17, 2022, 16:30 ET Company Participants Brian Kearns - SVP, Business Development & IR David Demski - CEO, President & Director Keith Pfeil - SVP & CFO Daniel Scavilla - EVP, Chief Commercial Officer & President, Trauma Conference Call Participants...

SA Transcripts on Seeking Alpha | February 18, 2022

Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin Up

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Yahoo | February 18, 2022

Globus Medical's Q4 Earnings Beat Estimates, But FY22 Outlook Lags

View more earnings on GMEDSee more from BenzingaShockwave Medical Reports Turnaround Q4 Profit On 270% Sales Growth; Guides Above ConsensusQuidel's Q4 Earnings Beat Street View Despite 21% Decline In Sales© 2022 Benzinga does not provide investment advice. All rights reserved.

Yahoo | February 18, 2022

Globus Medical (GMED) Q4 2021 Earnings Call Transcript

Joining today's call from Globus Medical will be Dave Demski, president, and CEO; Dan Scavilla, executive vice president and president of Ortho; and Keith Pfeil, senior vice president, and chief financial officer. This review is being made available via webcast accessible through the investor relations section of the Globus Medical website at

Yahoo | February 18, 2022

Globus Medical (GMED) Tops Q4 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 2.08% and 2.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 17, 2022

Globus Medical Reports Fourth Quarter and Full Year 2021 Results

AUDUBON, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, 2021. Fourth Quarter 2021: Worldwide net sales were $250.0 million, an increase of 7.1% as compared to the fourth quarter of 2020GAAP net income for the quarter was $15.1 millionGAAP diluted earnings per share (“EPS”) was $0.14 and non-GAAP diluted EPS was $0.49Non-GAAP adjusted EBI

Yahoo | February 17, 2022

8 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital

In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt’s Consonance Capital. You can skip our detailed analysis of these stocks and head directly to 3 Medical Stocks to Buy According to Mitchell Blutt’s Consonance Capital. Mitchell Blutt is an American physician-businessman. He is one of the […]

Yahoo | February 15, 2022

Earnings Preview: Globus Medical (GMED) Q4 Earnings Expected to Decline

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | February 10, 2022

How Did Hedge Funds’ Globus Medical Inc (GMED) Bets Fare?

We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]

Yahoo | February 5, 2022

Compass Ion Advisors, LLC Buys iShares Core Moderate Allocation ETF, Vanguard Total World Stock ...

Investment company Compass Ion Advisors, LLC (Current Portfolio) buys iShares Core Moderate Allocation ETF, Vanguard Total World Stock ETF, Vanguard U.S.

Yahoo | February 2, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6712 seconds.